Carfilzomib intermediate-1
Carfilzomib intermediate-1 (Intermediate IV) is a key intermediate for Carfilzomib (HY-10455) synthesis[1].
Product Specifications
CAS Number
[868540-16-3]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Intermediate
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.15
Smiles
OC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@H](CCC2=CC=CC=C2)NC(CN3CCOCC3)=O)=O)CC(C)C)=O)=O
Molecular Formula
C31H42N4O6
Molecular Weight
566.69
Precautions
H302, H315, H319, H335
References & Citations
[1] Huang Chun, et al. Hydrogenation method of carfilzomib intermediate. Patent. CN117247426
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15116051 1 Vial
Lentiviral human PIP4P1 shRNA (UAS) - Lentiviral human PIP4P1 shRNA (UAS, RFP) (25)
Ask
View Details MBS6351366-01 0.2 mL
SSR4, ID (SSR4, TRAPD, Translocon-associated protein subunit delta, Signal sequence receptor subunit delta) (PE)
Ask
View Details MBS6351366-02 5x 0.2 mL
SSR4, ID (SSR4, TRAPD, Translocon-associated protein subunit delta, Signal sequence receptor subunit delta) (PE)
Ask
View Details